{"id":168961,"date":"2022-02-15T11:00:14","date_gmt":"2022-02-15T16:00:15","guid":{"rendered":"https:\/\/cafc.uscourts.gov\/?p=168961"},"modified":"2022-02-15T11:00:14","modified_gmt":"2022-02-15T16:00:15","slug":"02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342","status":"publish","type":"post","link":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/","title":{"rendered":"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential"},"content":{"rendered":"<p>RULE 36 JUDGMENT Posted: <\/p>\n<p><a href=\"\/opinions-orders\/21-2024.RULE_36_JUDGMENT.2-15-2022_1908342.pdf\">AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT](pdf)<\/a> <br \/>Appeal Number: 21-2024 <br \/>Origin: DCT <br \/>Nonprecedential <\/p>\n<p>To see more opinions and orders, follow this link: <a href=\"\/home\/case-information\/opinions-orders\/\">Opinions and Orders<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RULE 36 JUDGMENT Posted: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT](pdf) Appeal Number: 21-2024 Origin: DCT Nonprecedential To see more opinions and orders, follow this link: Opinions and Orders.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit\" \/>\n<meta property=\"og:description\" content=\"RULE 36 JUDGMENT Posted: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT](pdf) Appeal Number: 21-2024 Origin: DCT Nonprecedential To see more opinions and orders, follow this link: Opinions and Orders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\" \/>\n<meta property=\"og:site_name\" content=\"U.S. Court of Appeals for the Federal Circuit\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-15T16:00:15+00:00\" \/>\n<meta name=\"author\" content=\"25005pwpadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"25005pwpadmin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\"},\"author\":{\"name\":\"25005pwpadmin\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/33cd610825c7ecdfaf4663fbe9d8fc64\"},\"headline\":\"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential\",\"datePublished\":\"2022-02-15T16:00:15+00:00\",\"dateModified\":\"2022-02-15T16:00:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\"},\"wordCount\":44,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/#organization\"},\"articleSection\":[\"Opinion-Order\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\",\"url\":\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\",\"name\":\"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit\",\"isPartOf\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/#website\"},\"datePublished\":\"2022-02-15T16:00:15+00:00\",\"dateModified\":\"2022-02-15T16:00:15+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#website\",\"url\":\"https:\/\/cafc.uscourts.gov\/\",\"name\":\"U.S. Court of Appeals for the Federal Circuit\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cafc.uscourts.gov\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#organization\",\"name\":\"US Court of Appeals for the Federal Circuit\",\"url\":\"https:\/\/cafc.uscourts.gov\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"US Court of Appeals for the Federal Circuit\"},\"image\":{\"@id\":\"https:\/\/cafc.uscourts.gov\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/33cd610825c7ecdfaf4663fbe9d8fc64\",\"name\":\"25005pwpadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/989f81c2201e672460a9f0b802504110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/989f81c2201e672460a9f0b802504110?s=96&d=mm&r=g\",\"caption\":\"25005pwpadmin\"},\"sameAs\":[\"http:\/\/support.pagely.com\"],\"url\":\"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/","og_locale":"en_US","og_type":"article","og_title":"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit","og_description":"RULE 36 JUDGMENT Posted: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT](pdf) Appeal Number: 21-2024 Origin: DCT Nonprecedential To see more opinions and orders, follow this link: Opinions and Orders.","og_url":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/","og_site_name":"U.S. Court of Appeals for the Federal Circuit","article_published_time":"2022-02-15T16:00:15+00:00","author":"25005pwpadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"25005pwpadmin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/#article","isPartOf":{"@id":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/"},"author":{"name":"25005pwpadmin","@id":"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/33cd610825c7ecdfaf4663fbe9d8fc64"},"headline":"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential","datePublished":"2022-02-15T16:00:15+00:00","dateModified":"2022-02-15T16:00:15+00:00","mainEntityOfPage":{"@id":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/"},"wordCount":44,"commentCount":0,"publisher":{"@id":"https:\/\/cafc.uscourts.gov\/#organization"},"articleSection":["Opinion-Order"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/","url":"https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/","name":"21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], Nonprecedential - U.S. Court of Appeals for the Federal Circuit","isPartOf":{"@id":"https:\/\/cafc.uscourts.gov\/#website"},"datePublished":"2022-02-15T16:00:15+00:00","dateModified":"2022-02-15T16:00:15+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cafc.uscourts.gov\/02-15-2022-21-2024-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc-rule-36-judgment-21-2024-rule_36_judgment-2-15-2022_1908342\/"]}]},{"@type":"WebSite","@id":"https:\/\/cafc.uscourts.gov\/#website","url":"https:\/\/cafc.uscourts.gov\/","name":"U.S. Court of Appeals for the Federal Circuit","description":"","publisher":{"@id":"https:\/\/cafc.uscourts.gov\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cafc.uscourts.gov\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cafc.uscourts.gov\/#organization","name":"US Court of Appeals for the Federal Circuit","url":"https:\/\/cafc.uscourts.gov\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cafc.uscourts.gov\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"US Court of Appeals for the Federal Circuit"},"image":{"@id":"https:\/\/cafc.uscourts.gov\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/33cd610825c7ecdfaf4663fbe9d8fc64","name":"25005pwpadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cafc.uscourts.gov\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/989f81c2201e672460a9f0b802504110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/989f81c2201e672460a9f0b802504110?s=96&d=mm&r=g","caption":"25005pwpadmin"},"sameAs":["http:\/\/support.pagely.com"],"url":"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/posts\/168961"}],"collection":[{"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/comments?post=168961"}],"version-history":[{"count":0,"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/posts\/168961\/revisions"}],"wp:attachment":[{"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/media?parent=168961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/categories?post=168961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cafc.uscourts.gov\/wp-json\/wp\/v2\/tags?post=168961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}